Providing enabling technologies to support you from Discovery to Delivery.
› News › Application and Technology News
Esco Pharma introduces the newest member to its isolation technologies, the Isoclean® Healthcare Platform Isolator - Inflatable Seal Model (HPI-G3-IS). Isoclean® HPI is offered as an optimized solution for aseptic and potent compounding, sterility testing, aseptic filtration, cell and gene therapy, cosmeceuticals, and biocontainment, among others.
Esco Pharma introduces the newest member to its isolation technologies, the Isoclean® Healthcare Platform Isolator - Inflatable Seal Model (HPI-G3-IS). Isoclean® HPI is offered as an optimized solution for aseptic and potent compounding, sterility testing, aseptic filtration, cell and gene therapy, cosmeceuticals, and biocontainment, among others.
The entire process of pharmaceutical manufacturing involves a whole list of meticulous guidelines, both local and international, to adhere to. Moreover, it needs to pass the different stages of production before it can reach market platforms, and only then can the industry be assured of their product’s quality.
There have been many great feats made by the pharmaceutical industry in the past few years, but there is one that bothers both the healthcare and manufacturing industries continuous soar, the possibility of health decline and a high risk of bioburden.
Contamination control is of extreme importance in biopharmaceutical industries, especially in maintaining product quality and sterility. As standards and guidelines evolved over time, biodecontamination became a part of the standard operating procedures (SOPs) for facilities who manufacture and handle high-quality products.
Pharmaceutical industries need to gain a high degree of assurance that their manufacturing processes are consistently producing marketable drug products with the necessary attributes of identity, strength, quality, purity, and potency.
Novel drugs do not just appear overnight, rather, they are borne from the ceaseless sacrifice of dedicated researchers. The story starts with exhaustively studying a promising compound and ends with a safe and properly documented final drug product in the market.
Recent studies on antibiotic occupational exposure has shown evidences of high AMR levels and various adverse health effects among production line workers without proper equipment to isolate them from the process.
